TLOG / TetraLogic Pharmaceuticals Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5

TetraLogic Pharmaceuticals Corporation
US ˙ OTCPK

Deler fremragende 24,315,086 shares
Insideraktier15.464.267 shares
Insider ejerskab63,60 %
Total Insiders29
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

8365 out of 11308

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

8359 out of 11219

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

TetraLogic Pharmaceuticals Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Amgen Inc 10% Owner - [10%] 541.399 541.399
Amgen Ventures LLC 10% Owner - [10%] 541.399 541.399
J Kevin Buchi President & CEO, Director - [D] [O] 330.714 330.714
Colin Glenn Begley Chief Scientific Officer & SVP - [O] 198.134 198.134
James H Cavanaugh 10% Owner - [10%] 2.586.466 2.586.466
Clarus Lifesciences II, L.P. 10% Owner - [10%] 2.214.523 2.214.523
Geode Capital Management Lp 1.257.144
John Gill Director - [D] 40.312 40.312
Mary Ann Gray 30.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Brenda D Gavin Director - [D] 948.268 948.268
Healthcare Ventures Vii Lp 10% Owner - [10%] 2.586.466 2.586.466
Hudson Bay Capital Management LP 279.367
Patrick Hutchison CFO & Treasurer - [O] 14.000 14.000
Michael D Kishbauch 30.000
Lazard Asset Management Llc 1.463.594
Linden Advisors Lp 2.095.239
Meyers Pete A. CFO & Treasurer - [O] 153.891 153.891
Nomura Securities International, Inc. 892.850
Douglas E Onsi Director - [D] 10.000 2.586.466
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Andrew L Pecora Director - [D] 184.830 184.830
Douglas MD Reed Director - [D] 1.209.742 1.209.742
Robins David C. 10% Owner - [10%] 6.000.000 6.000.000
Lesley Russell Chief Operating Officer - [O] 20.000 20.000
Paul J Schmitt Director - [D] 20.000 20.000
Sherman Richard L. 0
State of New Jersey Common Pension Fund D 911.011
Telemetry Securities, L.l.c. 838.094
Whitebox Advisors Llc 3.018.260
Woody James N. Director - [D] 1.001.988 1.001.988

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TLOG / TetraLogic Pharmaceuticals Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2015-07-10 Pecora Andrew L 9.200 2,7900 9.200 2,7900 25.668 5 2.85 552 2,15
2015-07-10 Pecora Andrew L 1.300 2,5400 1.300 2,5400 3.302
2015-07-10 Pecora Andrew L 800 2,7500 800 2,7500 2.200
2015-07-10 Pecora Andrew L 7.608 2,7450 7.608 2,7450 20.884
2015-07-10 Pecora Andrew L 6.900 2,7430 6.900 2,7430 18.927
2015-07-10 Pecora Andrew L 10.000 2,7370 10.000 2,7370 27.370
2015-07-10 Pecora Andrew L 2.100 2,6900 2.100 2,6900 5.649
2015-07-10 Pecora Andrew L 908 2,6590 908 2,6590 2.414
2015-07-10 Pecora Andrew L 1.092 2,6500 1.092 2,6500 2.894

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TLOG / TetraLogic Pharmaceuticals Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-02-09 Clarus Lifesciences II, L.P. 230.507 0,1600 230.507 0,1600 36.881 317 0.0301 -29.943 -81,19
2016-02-08 Clarus Lifesciences II, L.P. 103.123 0,1900 103.123 0,1900 19.593
2016-02-05 Clarus Lifesciences II, L.P. 832.881 0,2000 832.881 0,2000 166.576
2016-02-04 Clarus Lifesciences II, L.P. 500.026 0,1400 500.026 0,1400 70.004
2016-02-03 Clarus Lifesciences II, L.P. 82.583 0,1500 82.583 0,1500 12.387
2016-02-02 Clarus Lifesciences II, L.P. 176.306 0,1700 176.306 0,1700 29.972
2016-02-01 Clarus Lifesciences II, L.P. 140.000 0,2000 140.000 0,2000 28.000
2016-01-29 Clarus Lifesciences II, L.P. 52.826 0,2600 52.826 0,2600 13.735
2016-01-28 Clarus Lifesciences II, L.P. 32.521 0,2600 32.521 0,2600 8.455

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2018-06-27 3 Robins David C. TLOG Common Stock D 6.000.000
2018-06-27 3 Robins David C. TLOG Common Stock D 6.000.000
2018-06-27 3 Robins David C. TLOG Common Stock D 6.000.000
2016-11-14 2016-11-14 4 LAZARD ASSET MANAGEMENT LLC TLOG 8% Senior Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 LAZARD ASSET MANAGEMENT LLC TLOG Preferred Stock J - Other I 1.463.594 1.463.594
2016-11-14 2016-11-14 4 LAZARD ASSET MANAGEMENT LLC TLOG 8% Senior Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 LINDEN ADVISORS LP TLOG Preferred Stock J - Other I 2.095.239 2.095.239
2016-11-14 2016-11-14 4 LINDEN ADVISORS LP TLOG 8% Senior Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 LINDEN ADVISORS LP TLOG 8% Senior Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 TELEMETRY SECURITIES, L.L.C. TLOG Preferred Stock J - Other D 838.094 838.094
2016-11-14 2016-11-14 4 TELEMETRY SECURITIES, L.L.C. TLOG 8% Senior Convertible Notes due 2024 J - Other D
2016-11-14 2016-11-14 4 TELEMETRY SECURITIES, L.L.C. TLOG 8% Senior Convertible Notes due 2019 J - Other D 0
2016-11-14 2016-11-14 4 GEODE CAPITAL MANAGEMENT LP TLOG Preferred Stock J - Other I 1.257.144 1.257.144
2016-11-14 2016-11-14 4 GEODE CAPITAL MANAGEMENT LP TLOG 8% Senior Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 GEODE CAPITAL MANAGEMENT LP TLOG 8% Senior Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 Hudson Bay Capital Management LP TLOG Preferred Stock J - Other I 279.367 279.367
2016-11-14 2016-11-14 4 Hudson Bay Capital Management LP TLOG 8% Senior Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 Hudson Bay Capital Management LP TLOG 8% Senior Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 State of New Jersey Common Pension Fund D TLOG 8% Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 State of New Jersey Common Pension Fund D TLOG Preferred Stock J - Other I 911.011 911.011
2016-11-14 2016-11-14 4 State of New Jersey Common Pension Fund D TLOG 8% Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 WHITEBOX ADVISORS LLC See Footnotes TLOG 8% Senior Convertible Notes due 2024 J - Other I
2016-11-14 2016-11-14 4 WHITEBOX ADVISORS LLC See Footnotes TLOG Preferred Stock J - Other I 3.018.260 3.018.260
2016-11-14 2016-11-14 4 WHITEBOX ADVISORS LLC See Footnotes TLOG 8% Senior Convertible Notes due 2019 J - Other I 0
2016-11-14 2016-11-14 4 NOMURA SECURITIES INTERNATIONAL, INC. TLOG Preferred Stock J - Other D 892.850 892.850
2016-11-14 2016-11-14 4 NOMURA SECURITIES INTERNATIONAL, INC. TLOG 8% Convertible Notes due 2024 J - Other D
2016-11-14 2016-11-14 4 NOMURA SECURITIES INTERNATIONAL, INC. TLOG 8% Convertible Notes due 2019 J - Other D 0
2016-05-09 3 Hutchison Patrick TLOG Common Stock D 14.000
2016-05-09 3 Hutchison Patrick TLOG Common Stock D 14.000
2016-02-10 2016-02-09 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,1600 -230.507 -37 2.214.523
2016-02-10 2016-02-08 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,1900 -103.123 -20 2.445.030
2016-02-05 2016-02-05 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,2000 -832.881 -167 2.548.153
2016-02-05 2016-02-04 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,1400 -500.026 -70 3.381.034
2016-02-05 2016-02-03 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,1500 -82.583 -12 3.881.060
2016-02-02 2016-02-02 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,1700 -176.306 -30 3.963.643
2016-02-02 2016-02-01 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,2000 -140.000 -28 4.139.949
2016-02-02 2016-01-29 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,2600 -52.826 -14 4.279.949
2016-01-28 2016-01-28 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,2600 -32.521 -8 4.332.775
2016-01-28 2016-01-27 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,2700 -209.984 -57 4.365.296
2016-01-28 2016-01-26 4 Clarus Lifesciences II, L.P. TLOG Common Stock S - Sale D 0,3000 -69.425 -21 4.575.280
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,7900 9.200 26 184.830
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,7500 800 2 175.630
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,7450 7.608 21 174.830
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,7430 6.900 19 167.222
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,7370 10.000 27 160.322
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,6900 2.100 6 150.322
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,6590 908 2 148.222
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,6500 1.092 3 147.314
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,5700 92 0 146.222
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,5400 1.300 3 146.130
2015-07-14 2015-07-10 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,4400 10.000 24 144.830
2015-07-13 2015-07-09 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,4090 10.000 24 134.830
2015-07-13 2015-07-09 4 Pecora Andrew L TLOG Common Stock P - Purchase D 2,4000 40.000 96 124.830
2015-07-06 2015-07-02 4 Schmitt Paul J TLOG Common Stock P - Purchase I 2,3366 6.500 15 20.000
2015-07-06 2015-07-02 4 Schmitt Paul J TLOG Common Stock P - Purchase I 2,3340 3.500 8 13.500
2015-03-31 2015-03-27 4 Meyers Pete A. TLOG Common Stock P - Purchase D 4,3500 5.000 22 153.891
2015-03-30 2015-03-26 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 4,2295 5.000 21 330.714
2015-01-30 2015-01-28 4 Schmitt Paul J TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 Russell Lesley TLOG Restricted Stock Unit A - Award D 75.000 0
2015-01-30 2015-01-28 4 Russell Lesley TLOG Stock Option A - Award D 5,25 5,2500 100.000 525 611.195
2015-01-30 2015-01-28 4 Reed Douglas MD TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 GRAY MARY ANN TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 BUCHI J KEVIN TLOG Restricted Stock Unit A - Award D 150.000 0
2015-01-30 2015-01-28 4 BUCHI J KEVIN TLOG Stock Option A - Award D 5,25 5,2500 200.000 1.050 1.222.389
2015-01-30 2015-01-28 4 STEINMETZ MICHAEL TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 KISHBAUCH MICHAEL D TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 Meyers Pete A. TLOG Restricted Stock Unit A - Award D 75.000 0
2015-01-30 2015-01-28 4 Meyers Pete A. TLOG Stock Option A - Award D 5,25 5,2500 100.000 525 611.195
2015-01-30 2015-01-28 4 Begley Colin Glenn TLOG Restricted Stock Unit A - Award D 75.000 0
2015-01-30 2015-01-28 4 Begley Colin Glenn TLOG Stock Option A - Award D 5,25 5,2500 100.000 525 173.705
2015-01-30 2015-01-28 4 Sherman Richard L. TLOG Restricted Stock Unit A - Award D 75.000 0
2015-01-30 2015-01-28 4 Sherman Richard L. TLOG Stock Option A - Award D 5,25 5,2500 100.000 525 424.705
2015-01-30 2015-01-28 4 Woody James N. TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 30.000
2015-01-30 2015-01-28 4 Pecora Andrew L TLOG Stock Option A - Award D 5,25 5,2500 10.000 52 77.644
2015-01-29 2015-01-28 4 ONSI DOUGLAS E TLOG Stock Option (Right to Buy) A - Award D 5,25 10.000 10.000
2015-01-09 2015-01-07 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 5,0362 5.000 25 325.714
2014-12-12 2014-12-10 4 Begley Colin Glenn TLOG Common Stock - Colin Glenn Begley P - Purchase D 6,1600 5.900 36 198.134
2014-12-11 2014-12-09 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 6,0120 5.000 30 320.714
2014-12-08 2014-12-04 4 Meyers Pete A. TLOG Common Stock P - Purchase D 4,9400 1.034 5 148.891
2014-12-04 2014-12-02 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 4,9900 10.000 50 315.714
2014-12-01 2014-11-26 4 Begley Colin Glenn By family member TLOG Common Stock, Ryan Alexander Begley (Son) P - Purchase I 4,8654 1.100 5 1.100
2014-12-01 2014-11-26 4 Begley Colin Glenn TLOG Common Stock, Colin Glenn Begley P - Purchase D 4,9000 1.000 5 192.234
2014-12-01 2014-11-26 4 Begley Colin Glenn TLOG Common Stock, Colin Glenn Begley P - Purchase D 4,8100 1.000 5 191.234
2014-12-01 2014-11-26 4 Russell Lesley TLOG Common Stock P - Purchase D 4,8985 20.000 98 20.000
2014-11-28 2014-11-25 4 Begley Colin Glenn TLOG Common Stock P - Purchase D 4,8400 100 0 190.234
2014-11-28 2014-11-25 4 Begley Colin Glenn TLOG Common Stock P - Purchase D 4,8400 200 1 190.134
2014-11-28 2014-11-25 4 Begley Colin Glenn TLOG Common Stock P - Purchase D 4,8470 500 2 189.934
2014-11-28 2014-11-25 4 Begley Colin Glenn TLOG Common Stock P - Purchase D 4,8450 500 2 189.434
2014-11-28 2014-11-25 4 Begley Colin Glenn TLOG Common Stock P - Purchase D 4,8699 700 3 188.934
2014-11-20 2014-11-18 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 4,8185 10.000 48 305.714
2014-11-19 2014-11-17 4 Pecora Andrew L TLOG Common Stock P - Purchase I 4,5320 20.000 91 84.830
2014-11-13 2014-11-11 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 3,9325 10.000 39 295.714
2014-11-13 2014-11-12 4 Meyers Pete A. TLOG Common Stock P - Purchase D 3,9780 5.000 20 147.857
2014-11-12 2014-11-10 4 Schmitt Paul J TLOG Common Stock P - Purchase I 4,1352 10.000 41 10.000
2014-11-12 2014-11-10 4 Schmitt Paul J TLOG Common Stock P - Purchase D 4,0630 10.000 41 10.000
2014-11-07 2014-11-05 4 GRAY MARY ANN TLOG Stock Options (right to buy) A - Award D 3,87 20.000 20.000
2014-11-07 2014-11-05 4 KISHBAUCH MICHAEL D TLOG Stock Options (right to buy) A - Award D 3,87 20.000 20.000
2014-06-09 2014-04-22 4 Sherman Richard L. TLOG Stock Option (Right to Buy) A - Award D 6,65 100.000 324.705
2013-12-19 2013-12-17 4 Reed Douglas MD See footnotes TLOG Warrants X - Other I 6,40 -7.590 0
2013-12-19 2013-12-17 4 Reed Douglas MD See footnotes TLOG Convertible Notes C - Conversion I 7,00 -278.315 0
2013-12-19 2013-12-17 4 Reed Douglas MD See footnotes TLOG Series C Convertible Stock C - Conversion I -780.980 0
2013-12-19 2013-12-17 4 Reed Douglas MD TLOG Common Stock X - Other I 6,4022 7.590 49 1.209.742
2013-12-19 2013-12-17 4 Reed Douglas MD TLOG Common Stock C - Conversion I 7,0000 278.315 1.948 1.202.152
2013-12-19 2013-12-17 4 Reed Douglas MD TLOG Common Stock C - Conversion I 780.980 923.837
2013-12-19 2013-12-17 4 Reed Douglas MD TLOG Common Stock P - Purchase I 7,0000 142.857 1.000 142.857
2013-12-19 2013-12-17 4 BUCHI J KEVIN TLOG Stock Option A - Award D 7,00 7,0000 167.040 1.169 975.775
2013-12-19 2013-12-17 4 BUCHI J KEVIN TLOG Common Stock P - Purchase D 7,0000 285.714 2.000 285.714
2013-12-19 2013-12-17 4 Russell Lesley TLOG Stock Option (right to purchase) A - Award D 7,00 7,0000 164.394 1.151 487.888
2013-12-19 2013-12-17 4 Schmitt Paul J See footnotes TLOG Series C Warrants X - Other I 6,40 6,4022 -5.305 -34 0
2013-12-19 2013-12-17 4 Schmitt Paul J See footnotes TLOG Convertible Notes C - Conversion I 7,00 -193.863 0
2013-12-19 2013-12-17 4 Schmitt Paul J See footnotes TLOG Series C Convertible Preferred Stock C - Conversion I -427.440 0
2013-12-19 2013-12-17 4 Schmitt Paul J See footnotes TLOG Series B Convertible Preferred Stock C - Conversion I -179.738 0
2013-12-19 2013-12-17 4 Schmitt Paul J See footnotes TLOG Series A Convertible Preferred Stock C - Conversion I -261.437 0
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock X - Other I 6,4022 5.305 34 1.512.962
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock C - Conversion I 7,0000 193.863 1.357 1.507.657
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock C - Conversion I 427.440 1.313.794
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock C - Conversion I 179.738 886.354
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock C - Conversion I 261.437 706.616
2013-12-19 2013-12-17 4 Schmitt Paul J TLOG Common Stock P - Purchase I 7,0000 445.179 3.116 445.179
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Warrants X - Other D 6,40 6,4022 -23.282 -149 0
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Convertible Notes C - Conversion D 7,00 -853.416 0
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Series C Convertible Preferred Stock C - Conversion D -2.342.944 0
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Common Stock X - Other D 6,4022 23.282 149 4.644.705
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Common Stock C - Conversion D 7,0000 853.416 5.974 4.621.423
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Common Stock C - Conversion D 2.342.944 3.768.007
2013-12-19 2013-12-17 4 Clarus Lifesciences II, L.P. TLOG Common Stock P - Purchase D 7,0000 1.425.063 9.975 1.425.063
2013-12-19 2013-12-17 4 Gavin Brenda D TLOG Convertible Notes C - Conversion I 7,00 -48.183 0
2013-12-19 2013-12-17 4 Gavin Brenda D TLOG Common Stock C - Conversion I 7,0000 48.183 337 948.268
2013-12-19 2013-12-17 4 Pecora Andrew L See footnotes TLOG Series C Warrants X - Other I 6,40 -161 0
2013-12-19 2013-12-17 4 Pecora Andrew L See footnotes TLOG Convertible Notes C - Conversion I 7,00 -5.887 0
2013-12-19 2013-12-17 4 Pecora Andrew L See footnotes TLOG Series C Convertible Preferred Stock C - Conversion I -16.055 0
2013-12-19 2013-12-17 4 Pecora Andrew L TLOG Common Stock X - Other I 6,4022 161 1 64.830
2013-12-19 2013-12-17 4 Pecora Andrew L TLOG Common Stock C - Conversion I 7,0000 5.887 41 64.669
2013-12-19 2013-12-17 4 Pecora Andrew L TLOG Common Stock C - Conversion I 16.055 58.782
2013-12-19 2013-12-17 4 Pecora Andrew L TLOG Common Stock P - Purchase I 7,0000 26.551 186 42.727
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Warrants X - Other I 6,40 -71 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Warrants X - Other I 6,40 -143 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Warrants X - Other I 6,40 -2.850 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Convertible Notes C - Conversion I 7,00 -2.602 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Convertible Notes C - Conversion I 7,00 -5.205 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Convertible Notes C - Conversion I 7,00 -104.118 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Convertible Preferred Stock C - Conversion I -5.681 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Convertible Preferred Stock C - Conversion I -11.363 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series C Convertible Preferred Stock C - Conversion I -227.266 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series B Convertible Preferred Stock C - Conversion I -8.866 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series B Convertible Preferred Stock C - Conversion I -17.733 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Series B Convertible Preferred Stock C - Conversion I -354.663 0
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock X - Other I 6,4022 71 0 1.001.988
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock X - Other I 6,4022 143 1 1.001.917
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock X - Other I 6,4022 2.850 18 1.001.774
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 7,0000 2.602 18 998.924
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 7,0000 5.205 36 996.322
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 7,0000 104.118 729 991.117
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 5.681 886.999
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 11.363 881.318
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 227.266 869.955
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 8.866 642.689
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 17.733 633.823
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock C - Conversion I 354.663 616.090
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock P - Purchase I 7,0000 6.079 43 261.427
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock P - Purchase I 7,0000 12.159 85 255.348
2013-12-19 2013-12-17 4 Woody James N. See footnotes TLOG Common Stock P - Purchase I 7,0000 243.189 1.702 243.189
2013-12-19 2013-12-17 4 Meyers Pete A. TLOG Stock Option A - Award D 7,00 7,0000 164.394 1.151 487.888
2013-12-19 2013-12-17 4 Meyers Pete A. TLOG Common Stock P - Purchase D 7,0000 142.857 1.000 142.857
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Series C Convertible Preferred Stock Warrants (Right To Buy) X - Other I 6,40 -13.355 0
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Convertible Notes C - Conversion I 7,00 0
2013-12-18 2013-12-17 4 AMGEN INC TLOG Convertible Notes C - Conversion D 7,00 0
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Series C Convertible Preferred Stock C - Conversion I -117.361 0
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Series B Convertible Preferred Stock C - Conversion I -108.932 0
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Common Stock P - Purchase I 7,0000 272.142 1.905 541.399
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Common Stock X - Other I 6,4022 1.141 7 269.257
2013-12-18 2013-12-17 4 AMGEN INC By Ventures TLOG Common Stock C - Conversion I 268.116 268.116
2013-12-18 2013-12-17 4 AMGEN INC TLOG Common Stock C - Conversion D 448.767 448.767
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Notes C - Conversion I 7,00 0
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Series A Preferred Stock C - Conversion I 0,00 -5.000.000 0
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Preferred Stock Warrant C - Conversion I 6,40 0
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Series C Preferred Stock C - Conversion I 0,00 -8.603.477 0
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Series B Preferred Stock C - Conversion I 0,00 -7.453.704 0
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock P - Purchase I 7,0000 713.463 4.994 2.586.466
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock C - Conversion I 7,0000 267.535 1.873 1.873.003
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock C - Conversion I 6,4022 7.335 47 1.605.468
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock C - Conversion I 506.086 1.598.133
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock C - Conversion I 438.453 1.092.047
2013-12-17 2013-12-17 4 HEALTHCARE VENTURES VII LP TLOG Common Stock C - Conversion I 653.594 653.594
2013-12-11 3 CAVANAUGH JAMES H TLOG Common Stock D 0
2013-12-11 3 GILL JOHN TLOG Common Stock D 40.312
2013-12-11 3 Gavin Brenda D By: Quaker BioVentures Tobacco Fund, L.P. TLOG Common Stock I 275.245
2013-12-11 3 Gavin Brenda D By: BioAdvance Ventures, L.P. TLOG Common Stock I 175.518
2013-12-11 3 Gavin Brenda D By: Quaker BioVentures, L.P. TLOG Common Stock I 449.322
2013-12-11 3 Pecora Andrew L TLOG Common Stock D 16.176
2013-12-11 3 Begley Colin Glenn TLOG Common Stock D 141.176
2013-12-11 3 Begley Colin Glenn TLOG Common Stock D 47.058
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista